
RGC P/E Ratio
P/E Ratio as of Jun 13, 2025: -47.37
Average-46.29
Median-48.54
Minimum-69.81
Maximum-28.02
-47.37
Past Month-15.37 (48.03%)
The P/E ratio for RGC is -47.37 as of Jun 13, 2025. This represents a increase of 690.82% compared to its 12-month average P/E ratio of -5.99. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Regencell Bioscience Holdings Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Regencell Bioscience Holdings Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Regencell Bioscience Holdings Ltd to industry peers.
Regencell Bioscience Holdings Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Regencell Bioscience Holdings Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Regencell Bioscience Holdings Ltd to industry peers.
RGC P/E Ratio Insights
See Regencell Bioscience Holdings Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in RGC
Order type
Buy in
Order amount
Est. shares
0 shares
RGC P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $19.6839 | -59.54 |
May 1, 2025 | $2.0263 | -6.13 |
Apr 1, 2025 | $0.7629 | -2.31 |
Mar 3, 2025 | $0.1066 | -0.32 |
Feb 3, 2025 | $0.1003 | -0.30 |
Jan 2, 2025 | $0.1268 | -0.38 |
RGC End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -47.37 | +12,046.15% |
2024 | -0.39 | -36.07% |
2023 | -0.61 | -51.59% |
2022 | -1.26 | — |
FAQs About Regencell Bioscience Holdings Ltd (RGC) P/E ratio
The latest P/E ratio of RGC is -47.37, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Regencell Bioscience Holdings Ltd’s last 12-month average P/E ratio is -5.99, compared to its current P/E ratio of -47.37. This reflects a increase of 690.82%.
Regencell Bioscience Holdings Ltd’s current P/E ratio of -47.37 is higher than its last 12-month average P/E of -5.99. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Regencell Bioscience Holdings Ltd’s average P/E ratio over the last 3 years is -2.67. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Regencell Bioscience Holdings Ltd’s average P/E ratio over the last 5 years is -1.63. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.